Business Wire

Global Immunization Possible by 2022 With Fair Vaccine Distribution, Says WHO COVID-19 Special Envoy

11.3.2021 13:00:00 EET | Business Wire | Press release

Share

The World Government Summit Dialogues saw world leaders outline solutions to humanity’s most urgent challenges during the virtual event on 9-10 March.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210311005126/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The World Government Summit Dialogues saw world leaders outline solutions to humanity’s most urgent challenges (Photo: AETOSWire)

Dr. David Nabarro, Special Envoy on COVID-19 to the World Health Organization (WHO), claimed the unfair weighting of vaccine access in favour of rich countries will delay the global recovery from the healthcare and economic crises, potentially beyond 2022.

“While the COVAX effort is commendable, if a few countries take the majority of the supplies and leave minimal cash and vaccine supplies behind for the rest, this is not ethical,” Dr. Nabarro said.

The current “free-for-all” approach to vaccine supplies with “a small number of nations trying to outbid one another”, doesn’t work. But “fair access to vaccine for everybody, the objective for immunization, at least by 2022, is a reasonable prospect,” he said.

Earlier, Dr. Tedros Ghebreyesus, Director-General, WHO, said: “Vaccine nationalism will only prolong the pandemic, and the human and economic suffering that goes with it. Health must be seen not as a cost to be contained but as an investment in productive and resilient populations, and a key to sustainable development.”

Later, the Right Honourable Lord Martin Rees, President, the Royal Society, said reasons to study and explore other planets must be carefully considered. He claimed: “The idea of Elon Musk to have a million people settle on Mars is a dangerous delusion. Living on Mars is no better than living on the South Pole or the tip of Mount Everest.

“The only reason for humans to go to space would be for adventure. To live on Mars is not going to be easy. Mars has a hostile environment.”

His thoughts were backed-up by the eminent astrophysicist, Dr. Neil deGrasse Tyson, who said: “To ship a billion people to another planet to help them survive a catastrophe on earth seems unrealistic.”

The World Government Summit Dialogues convened leaders from around the world virtually to predict the trends that will shape the future, post-pandemic society. For more details about the event, visit: https://www.worldgovernmentsummit.org/

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

APCO Worldwide
Mahmoud Kandil, +971551266801
mkandil@apcoworldwide.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

REVEAL GENOMICS Aligns Founder Leadership With Priorities to Support Long-term Growth, Scientific Excellence, and Global Partnerships27.1.2026 14:43:00 EET | Press release

REVEAL GENOMICS, a Barcelona-based biotechnology company that advances precision oncology through biomarker innovation, today announced a strengthened leadership framework with several senior appointments. These appointments underscore the company’s commitment to scientific excellence, technological rigor, and clinical impact, and they seek to support the continued development, validation, and global adoption of the company’s genomic assays. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127015446/en/ The company appoints Ana Vivancos, Ph.D., as Director of NGS and Genomic Technologies; Joel Parker, Ph.D., as Chief Scientific Officer; and Aleix Prat, M.D., Ph.D., as Chairman of the Board of Directors. The roles are assumed by co-founders of REVEAL GENOMICS and are a reflection of the company’s strong internal leadership, continuity of vision, and long-term commitment to its scientific and clinical mission. By aligning its

Bial Achieves Key Milestone in Phase 2b ACTIVATE Study of BIA 28-6156 in GBA1-Associated Parkinson’s Disease27.1.2026 13:00:00 EET | Press release

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that 75% of patients currently enrolled in its ongoing Phase 2b clinical study ACTIVATE (ClinicalTrials.gov identifier: NCT05819359) have completed the double-blind treatment period through week 78. This operational milestone represents a significant step toward the completion of the ACTIVATE study, which is evaluating the efficacy, safety, tolerability, pharmacodynamics, and pharmacokinetics of BIA 28-6156 in patients with Parkinson’s disease (PD) who have a pathogenic mutation in the glucocerebrosidase 1 (GBA1) gene (GBA-PD). The date of the Last Patient, Last Visit (LPLV) is anticipated in April 2026, with topline results on track to be released in mid-2026. “We look forward to presenting data from our Phase 2b study. BIA 28-6156 is the leading asset in GBA-PD, and clinical outcomes are just around the corner,” said António Portela, CEO of Bial. “We are witnessing growing

Libraesva and Cyber Guru Announce Strategic Combination to Create a Leading European Human-Centric Cybersecurity Provider27.1.2026 12:00:00 EET | Press release

Cyber Guru and Libraesva today announced a strategic combination that brings together two highly complementary Italian cybersecurity companies to form a new European leader in human-centric cyber protection. The combined group will offer organisations an integrated approach to defending against email-based threats, social engineering, and human-targeted attacks, integrating advanced technology with behavioural resilience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127531600/en/ Cyber threats are evolving rapidly, with attackers focusing less on infrastructure and more on the weak link in security – human behaviour. Phishing, business email compromise, smishing, QR-code attacks, social engineering and many other forms of attacks targeting humans continue to be primary breach vectors and are rapidly growing in sophistication with support of widely available AI tools. By integrating Libraesva’s advanced, privacy-first em

Europe’s First Meteorological Infrared Sounder Reveals the Atmosphere in 3D27.1.2026 11:30:00 EET | Press release

The first images from Europe’s pioneering meteorological infrared sounder were unveiled today at the EU Space Conference in Brussels, marking a major advance in the ability to monitor how the atmosphere evolves before and during severe weather. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127490399/en/ Full Earth disc image from the MTG-S Infrared Sounder showing a surface-temperature-sensitive channel, captured between 12:45 and 15:30 UTC on 15 November 2025. The image distinguishes land and sea surface temperatures as well as cloud-top temperatures, highlighting cloud structures and weather systems. Hot desert regions appear in red, while cold cloud tops are shown in blue. © Image: Data acquired on 15 November 2025 and processed by industrial partners Thales and OHB under the supervision of EUMETSAT and ESA. Visual produced by EUMETSAT. The images were captured by the Infrared Sounder (IRS) flying aboard Meteosat Thir

Clearwater Analytics Embeds AI into Beacon Risk Platform to Accelerate Model Validation and Exposure Analysis27.1.2026 11:00:00 EET | Press release

Clearwater Analytics(NYSE: CWAN), the most comprehensive technology platform for investment management, today announced breakthrough embedded agentic AI capabilities within Beacon by CWAN, its enterprise risk and quantitative analytics platform, enabling risk teams to accelerate model validation, exposure analysis, and decision-making. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126906084/en/ As regulatory scrutiny intensifies and portfolio complexity reaches unprecedented levels, traditional risk platforms are failing institutional investors when they need answers most. Built specifically for quantitative developers and risk professionals managing complex institutional portfolios, CWAN’s embedded AI operates within Beacon’s calculation engine itself, training the agents our clients deploy on data grounded in a firm’s actual positions, validated models, and real-time calculations. This breakthrough architecture process

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye